Medarex shares up as prostate cancer drug shows promise »

Posted By roxblog 5 months, 1 week ago in Health & Fitness
Prop it 2 Drop it

Shares of Medarex Inc (MEDX.O) rose as much as 22 percent Monday on a Mayo Clinic report that two prostate cancer patients became cancer-free after being treated with the company s experimental drug, ipilimumab, in combination with other therapies and surgery.

Read Full Story at roxblog-trends.blogspot.com »

34 Views Share Story 0 Comments Report

Submitted By:
roxblog

I'm a Blogger

Who Also Submitted:
Other Related Articles:

RSS Join the Discussion

+ Add Comment
Comments So Far: 0 (view all)
- Display

Add a Comment

Sign In With Your Propeller Account

Forgot your password?

Please keep your comments relevant to this story.

To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.

Submit a Story

Advertisement

Story Tags ?

being shares drug patients surgery combination prostate clinic cancer treated mayo

Hey! If you Sign In, you can add tags to this story!

Also Propping This Article

view all »

Also Dropping This Article

No one has dropped this story.

Also Submitted By

No one else has submitted this story.